AbCellera, Silence and InduPro all raise significant funding
AbCellera's $200M offering: The Vancouver biotech is selling shares after hitting the bar in a Phase 2 hot flashes trial on Monday. The Canadian drug developer has also ...
We haven't written up this one. Endpoints News has the full story — the link below goes straight to it.